Phathom Pharmaceuticals, Inc. (PHAT)
12.61
-0.18
(-1.41%)
USD |
NASDAQ |
Apr 16, 16:00
12.61
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Free Cash Flow : -167.00M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Replimune Group, Inc. | -283.27M |
| ANI Pharmaceuticals, Inc. | 150.90M |
| MannKind Corp. | 13.69M |
| Ocugen, Inc. | -57.15M |
| Ligand Pharmaceuticals, Inc. | 38.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.001M |
| Cash from Investing (Quarterly) | -0.087M |
| Cash from Financing (Quarterly) | -0.097M |
| Free Cash Flow Per Share (Quarterly) | -0.0689 |
| Free Cash Flow to Equity (Quarterly) | -11.12M |
| Free Cash Flow to Firm (Quarterly) | 11.33M |
| Free Cash Flow Yield | -18.16% |